We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 411

EMEA healthcare industry group newsletter - November 2015
  • Baker & McKenzie
  • European Union, France, Hungary, Italy, Netherlands, OECD, Spain
  • November 20 2015

The European Commission has released a new version (1.17) of its manual on borderline and classification in the Community regulatory framework for


CEPS publishes its annual report 20142015
  • Hogan Lovells
  • France
  • September 22 2015

The Economic Committee for Healthcare Products (CEPS) - which is notably in charge of setting up the economic policy and policy for proper use of


Le CEPS publie son rapport d'activité 20142015
  • Hogan Lovells
  • France
  • September 22 2015

Le Comité Economique des Produits de Santé (CEPS) qui est notamment en charge de l'élaboration de la politique économique et de bon usage du


Off-label reimbursement a new method for reducing drug prices?
  • CMS Cameron McKenna
  • France, Italy
  • February 20 2015

Significant new reimbursement legislation was passed in Italy and France during 2014, the effect of which is to relax the law on the off-label use and


Focus on regulatory law - December 2014
  • McDermott Will & Emery
  • France, Italy
  • January 8 2015

It is now possible to directly challenge before the French Supreme Administrative Court (Conseil d’État) decisions made by the General Rapporteur to


Competition news December 2014 (International French)
  • Dentons
  • European Union, France
  • December 24 2014

La Cour d’appel de Paris vient de réformer une décision de l’Autorité de la Concurrence, en considérant que les accords de commercialisation en


Competition news December 2014
  • Dentons
  • European Union, France
  • December 24 2014

The Paris Court of Appeal recently overturned a decision handed down by the French Competition Authority, considering that the marketing agreements


Focus on regulatory law - October 2014
  • McDermott Will & Emery
  • France
  • October 3 2014

The applicant claimed that the provisions of I, Article L. 430-8 of the French Commercial Code, which allows the Competition Authority to fine


Refusal to sell software punished as an abuse of dominance
  • Bryan Cave LLP
  • France
  • August 6 2014

Pursuant to a complaint in 2008 by Euris (a French company specialising in customer relations management (CRM) software for the pharmaceutical


Focus on regulatory law - July 2014
  • McDermott Will & Emery
  • France
  • July 16 2014

Having been notified of an appeal against the Competition Authority’s decision regarding a joint acquisition of retail trade warehouses, the Conseil